BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/12/2018 9:26:11 AM | Browse: 1093 | Download: 1784
 |
Received |
|
2017-10-23 02:39 |
 |
Peer-Review Started |
|
2017-10-25 01:10 |
 |
To Make the First Decision |
|
2017-11-09 08:40 |
 |
Return for Revision |
|
2017-11-10 00:56 |
 |
Revised |
|
2017-11-27 11:21 |
 |
Second Decision |
|
2017-12-01 08:24 |
 |
Accepted by Journal Editor-in-Chief |
|
2017-12-03 02:12 |
 |
Accepted by Executive Editor-in-Chief |
|
2017-12-07 00:21 |
 |
Articles in Press |
|
2017-12-07 00:21 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2018-01-08 18:25 |
 |
Publish the Manuscript Online |
|
2018-01-12 09:26 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Review |
Article Title |
Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yu Wang, Pei-Min Chen and Rong-Bin Liu |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Rong-Bin Liu, MD, Doctor, Doctor, Department of Ultrasound, Sun Yat-sen Memorial Hospital, No. 107, Yanjiang West Road, Yuexiu District, Guangzhou 510120, Guangdong Province, China. liurb3@mail2.sysu.edu.cn |
Key Words |
Plasma; SEPT9; Methylation; Colorectal cancer; Early detection |
Core Tip |
The methylated SEPT9 gene has been implicated as a biomarker for colorectal cancer associated with the pathogenesis of colorectal cancer (CRC). In this article, we reviewed the literature on the correlation of SEPT9 gene and colorectal cancer and the theoretical basis of the SEPT9 gene methylation assay. Then, we focused on the diagnostic performance of the SEPT9 gene methylation assay for CRC by analyzing the clinical trial studies and compared that assay with other methods. Finally, we discussed the limitations of the SEPT9 gene methylation assay in clinical application. We hope that this article can provide a comprehensive overview of the progress achieved in the SEPT9 methylation assay for both the basic and clinical sciences. |
Publish Date |
2018-01-12 09:26 |
Citation |
Wang Y, Chen PM, Liu RB. Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection. World J Gastrointest Oncol 2018; 10(1): 15-22 |
URL |
http://www.wjgnet.com/1948-5204/full/v10/i1/15.htm |
DOI |
http://dx.doi.org/10.4251/wjgo.v10.i1.15 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345